Uploaded June 2025 | Updated September 2026, 2 weeks ago
Dr. Shiksha Gallow currently serves as the Medical Director of the Holistic Integrative Healing Institute and is notably the first and only South African to sit on the Board of Directors of the Society of Cannabis Clinicians. Dr. Gallow’s passion lies in leveraging her medical and scientific expertise to develop Active Pharmaceutical Ingredients (APIs) from cannabis and other plant species to treat various conditions. She has achieved significant success in treating patients with autoimmune diseases and cancer, and she strongly advocates for patient access to safe and effective medicines that improve quality of life. #shorts #prostatecancer #cannabiseducation
At CannMed 25 she will present “Comprehensive Evaluation of the ‘Impact of Cannabinoids’ on Prostate Cancer: Integrating PSA, PET/CT Scans and Patient-Related Outcomes”
Watch Now: youtu.be/_Y3stR_JVkE
During the conversation, we discussed:
⦿ The variety of treatment options for prostate cancer and the role of cannabinoids may play
⦿ Results from an empirical study that evaluated how cannabinoid treatment impacts PSA levels PET/CT scans and patient reported outcomes
⦿ How patients were selected and grouped for the study
⦿ Future research opportunities
⦿ And more!
Thanks to This Episode’s Sponsor: PRICH Biotech
Dr. Shiksha Gallow currently serves as the Medical Director of the Holistic Integrative Healing Institute and is notably the first and only South African to sit on the Board of Directors of the Society of Cannabis Clinicians. Dr. Gallow’s passion lies in leveraging her medical and scientific expertise to develop Active Pharmaceutical Ingredients (APIs) from cannabis and other plant species to treat various conditions. She has achieved significant success in treating patients with autoimmune diseases and cancer, and she strongly advocates for patient access to safe and effective medicines that improve quality of life. #shorts #prostatecancer #cannabiseducation
At CannMed 25 she will present “Comprehensive Evaluation of the ‘Impact of Cannabinoids’ on Prostate Cancer: Integrating PSA, PET/CT Scans and Patient-Related Outcomes”
Watch Now: youtu.be/_Y3stR_JVkE
During the conversation, we discussed:
⦿ The variety of treatment options for prostate cancer and the role of cannabinoids may play
⦿ Results from an empirical study that evaluated how cannabinoid treatment impacts PSA levels PET/CT scans and patient reported outcomes
⦿ How patients were selected and grouped for the study
⦿ Future research opportunities
⦿ And more!
Thanks to This Episode’s Sponsor: PRICH Biotech
